Primary Record
prostaglandin D2
- In stock
- 3,298 g
- Purity
- 99.3 %
- CAS
- 41598-07-6
Compound Identifiers & Properties
- CAS
- 41598-07-6
- PubChem CID
- 448457
- SMILES
- CCCCC[C@@H](/C=C/[C@@H]1[C@H]([C@H](CC1=O)O)C/C=C\CCCC(=O)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
Names & Synonyms
- prostaglandin D2
- PGD2
- 11-Dehydroprostaglandin F2-alpha
- D2, Prostaglandin
- 41598-07-6
- prosta-glandin d2
- [3H]prostaglandin D2
- PROSTAGLANDIND2
- 11-Dehydroprostaglandin F2alpha
- RXY07S6CZ2
- UNII-RXY07S6CZ2
- AC1L9LZD
- RefChem:869890
- [3H]PGD2
- D06KBO
- D0H8QQ
- BRN 2170623
- 11-Dehydroprostaglandin F2 alpha
- DTXSID30897162
- PGD2 (Prostaglandin D2)
- BHMBVRSPMRCCGG-OUTUXVNYSA-N
- 11 Dehydroprostaglandin F2alpha
- BSPBio_001486
- Prostaglandin D2 (Standard)
- [3H]-PGD2
- CHEBI:15555
- 11 Dehydroprostaglandin F2 alpha
- F2alpha, 11-Dehydroprostaglandin
- BML1-F05
- GTPL1881
- GTPL1891
- orb1707860
- PGD(2)
- SCHEMBL2508829
- alpha, 11-Dehydroprostaglandin F2
- F2 alpha, 11-Dehydroprostaglandin
- C20H32O5
- CHEMBL1235252
- BDBM21544
- DTXCID401326582
- HMS1361K08
- HMS1791K08
- HMS1989K08
- HMS3402K08
- HMS3648M03
- [3H]11-dehydroprostaglandin F2-alpha
- 2004AH
- CID448457
- LMFA03010004
- MFCD00077857
- MSK164220
- ZINC85994848
- AKOS032954030
- Prostaglandin D2, >=95%, synthetic
- Prostaglandin D2, cell culture tested
- AT21894
- C20-H32-O5
- CID:448457
- DB02056
- HY-101988R
- IDI1_033956
- 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid
- NCGC00161284-01
- NCGC00161284-02
- NCGC00161284-03
- (5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate
- FP176166
- J16.416J
- MS-25470
- SID:53788536
- HY-101988
- LS-125822
- CS-0022427
- FT-0630621
- NS00073037
- (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate
- (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
- 5179-EP2272832A1
- 5179-EP2280006A1
- 5179-EP2281563A1
- 5179-EP2281813A1
- 5179-EP2281815A1
- 5179-EP2295409A1
- 5179-EP2301937A1
- 5179-EP2305640A2
- 5179-EP2316459A1
- 5179-EP2316824A1
- C00696
- (5Z,13E,15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid
- 198163-EP2270004A1
- 198163-EP2272825A2
- 198163-EP2272827A1
- 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoate
- D015230
- Q419750
- SR-01000946237
- A1203131
- SR-01000946237-1
- (5E,13E)-9,15-DIHYDROXY-11-OXOPROSTA-5,13-DIEN-1-OIC ACID
- Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9-alpha,13E,15S)-
- (5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid
- 9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E-dien-1-oic acid
- E8965369-341A-46F4-8677-2CEB4F9432BA
- PG2
- (5Z,13E)-(15S)-9,15-dihydroxy-11-oxoprosta-5,13-dienoate
- (5Z,13E)-(15S)-9,15-dihydroxy-11-oxoprosta-5,13-dienoic acid
- (5z,13e)-(15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate
- (5Z,13E)-(15S)-9a,15-Dihydroxy-11-oxoprosta-5,13-dienoate
- (5Z,13E)-(15S)-9a,15-Dihydroxy-11-oxoprosta-5,13-dienoic acid
- (5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate
- (5Z,13E,15S)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oate
- Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9alpha,13E,15S)-
- (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid
- (5z,13e)-(15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic acid
- (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoic acid
- (5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic acid
- (5Z,13E,15S)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid
- (5Z,9-alpha,13E,15S)-9,15-dihydroxy-11-oxo-Prosta-5,13-dien-1-oate
- (5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oate
- (5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oic acid
- (5Z,9-alpha,13E,15S)-9,15-dihydroxy-11-oxo-Prosta-5,13-dien-1-oic acid
- 9,15- DIHYDROXY-11-OXO-PROSTA-5,13-DIEN-1-OIC ACID, (5Z,9-.ALPHA.,13E,15S)
- (Z)-7-((1R,2R,5S)-5-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-3-oxocyclopentyl)hept-5-enoic acid
- (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxo-cyclopentyl]hept-5-enoic acid